Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Kura Oncology, Inc. (KURA)
USD10.91
-0.54 (-4.72%)
US NASDAQ Healthcare Biotechnology
Address
4930 Directors Place 92121
San Diego, CA, US
San Diego, CA, US
CEO
Troy Wilson
Website
kuraoncology.com
IPO
2015-09-16
CIK 1422143 ISIN US50127T1097
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company’s first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD10.91
-0.54 (-4.72%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
0.36
Float Shares
86.52M
Free Float %
97.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.07% | +1.39% | +8.72% | +14.08% | -11.24% | -8.76% | +63.45% | -25.12% | -62.08% | +206.80% | -36.80% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (16 ratings, all time)
Buy
Price Targets & DCF
Current price
10.91
Low
15.00
+37.5%
Consensus
27.33
+150.5%
Median
25.50
+133.7%
High
40.00
+266.6%
DCF (Unlevered)
21.16
+93.9%
DCF (Levered)
17.25
+58.1%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
93% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 12 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
23.00
+110.8%
|
| Last Quarter | 2 |
19.00
+74.2%
|
| Last Year | 6 |
27.33
+150.5%
|
| All Time | 13 |
24.69
+126.3%
|
Quality scores
Altman Z-Score
-2.20
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
1 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
4 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+25.2% ★ Q1'26: +29.5% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%-57.4% Q1'26: -25.8% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-139.6% Q1'26: -470.7% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-410.3% Q1'26: -431.5% (vs Q1'25)
-
ROIC Biotechnology: -16.1%— Q1'26: +68.8% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+1.8% ★ Q1'26: +1.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.07× Q1'26: -0.05× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 11 Rev. Ana. 10 EPS Ana. |
Dec 2027 10 Rev. Ana. 9 EPS Ana. |
Dec 2028 11 Rev. Ana. 10 EPS Ana. |
Dec 2029 5 Rev. Ana. 4 EPS Ana. |
Dec 2030 5 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
53.88M
est: 50.23M (+7.3%)
|
67.48M
est: 85.37M (-21.0%)
|
111.39M
59.04M – 267.60M
+30.5% YoY
|
228.51M
106.86M – 588.38M
+105.2% YoY
|
351.50M
351.47M – 351.52M
+53.8% YoY
|
664.60M
286.99M – 1.90B
+89.1% YoY
|
1.15B
497.00M – 3.30B
+73.2% YoY
|
| EBITDA |
-169.50M
est: 10.05M (-1,787.1%)
|
-275.83M
est: 17.07M (-1,715.4%)
|
22.28M
11.81M – 53.52M
+30.5% YoY
|
45.70M
21.37M – 117.68M
+105.2% YoY
|
70.30M
70.29M – 70.30M
+53.8% YoY
|
132.92M
57.40M – 380.58M
+89.1% YoY
|
230.19M
99.40M – 659.07M
+73.2% YoY
|
| EBIT |
-170.35M
est: 10.05M (-1,795.5%)
|
-276.86M
est: 17.07M (-1,721.4%)
|
22.28M
11.81M – 53.52M
+30.5% YoY
|
45.70M
21.37M – 117.68M
+105.2% YoY
|
70.30M
70.29M – 70.30M
+53.8% YoY
|
132.92M
57.40M – 380.58M
+89.1% YoY
|
230.19M
99.40M – 659.07M
+73.2% YoY
|
| Net Income |
-173.98M
est: -197.17M (+11.8%)
|
-278.67M
est: -278.67M (+0.0%)
|
-316.20M
-403.54M – -133.57M
-13.5% YoY
|
-245.17M
-325.63M – 33.54M
+22.5% YoY
|
-167.00M
-319.07M – 306.27M
+31.9% YoY
|
40.33M
10.54M – 138.02M
+124.2% YoY
|
295.42M
77.21M – 1.01B
+632.5% YoY
|
| SGA |
77.11M
est: 62.38M (+23.6%)
|
119.98M
est: 106.02M (+13.2%)
|
138.32M
73.32M – 332.31M
+30.5% YoY
|
283.77M
132.70M – 730.66M
+105.2% YoY
|
436.50M
436.46M – 436.53M
+53.8% YoY
|
825.31M
356.39M – 2.36B
+89.1% YoY
|
1.43B
617.18M – 4.09B
+73.2% YoY
|
| EPS |
-2.02
est: -2.45 (+17.6%)
|
-3.18
est: -2.87 (-10.8%)
|
-3.60
-4.60 – -1.52
-25.6% YoY
|
-2.63
-3.71 – 0.38
+27.1% YoY
|
-1.54
-3.64 – 3.49
+41.4% YoY
|
0.46
0.12 – 1.57
+129.8% YoY
|
3.37
0.88 – 11.53
+632.5% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-08 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-07 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-06 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-05 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-04 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-01 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-30 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-29 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-28 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-27 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-24 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-23 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-22 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-21 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-17 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-16 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-15 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-137.49M
OE per share TTM
-1.57
Owner's Yield
-16.42%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
45.1%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
54
Total invested
43.87M
Insider transactions (90d)
0
Beneficial owners (>5%)
34
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | (1) BlackRock, Inc. | 4.93M | 7.60% | 4.86M | — | 4.93M | — | HC | Delaware | 2021-01-29 | ↗ |
| 2 | EcoR1 Capital, LLC | 4.54M | 11.00% | — | 4.54M | — | 4.54M | IA, OO | Delaware | 2022-01-31 | ↗ |
| 3 | Oleg Nodelman | 4.54M | 11.00% | — | 4.54M | — | 4.54M | HC, IN | United States | 2022-01-31 | ↗ |
| 4 | Deerfield Management Company, L.P. | 4.37M | 5.89% | — | 4.37M | — | — | PN | Delaware | 2023-09-21 | ↗ |
| 5 | Deerfield Mgmt, L.P. | 4.37M | 5.89% | — | 4.37M | — | — | PN | Delaware | 2023-09-21 | ↗ |
| 6 | Deerfield Partners, L.P. | 4.37M | 5.89% | — | 4.37M | — | — | PN | Delaware | 2023-09-21 | ↗ |
| 7 | James E. Flynn | 4.37M | 5.89% | — | 4.37M | — | — | IN | Delaware | 2023-09-21 | ↗ |
| 8 | Peter Kolchinsky | 4.37M | 5.60% | — | 4.37M | — | — | HC, IN | Delaware | 2024-12-05 | ↗ |
| 9 | RA Capital Healthcare Fund, L.P. | 4.37M | 5.60% | — | 4.37M | — | — | PN | Delaware | 2024-12-05 | ↗ |
| 10 | RA Capital Management, L.P. | 4.37M | 5.60% | — | 4.37M | — | — | IA, PN | Delaware | 2024-12-05 | ↗ |
| 11 | Rajeev Shah | 4.37M | 5.60% | — | 4.37M | — | — | HC, IN | Delaware | 2024-12-05 | ↗ |
| 12 | EcoR1 Capital Fund Qualified, L.P. | 4.13M | 11.00% | — | 4.13M | — | 4.13M | PN | Delaware | 2022-01-31 | ↗ |
| 13 | Avoro Capital Advisors LLC | 4.00M | 6.20% | 4.00M | — | 4.00M | — | IA, OO | Delaware | 2021-02-12 | ↗ |
| 14 | Behzad Aghazadeh | 4.00M | 6.20% | 4.00M | — | 4.00M | — | IN | United States | 2021-02-12 | ↗ |
| 15 | Paradigm BioCapital Advisors LP | 3.86M | 5.10% | 3.86M | — | 3.86M | — | PN | Delaware | 2024-05-02 | ↗ |
| 16 | Aaron Cowen | 3.57M | 5.40% | — | 3.57M | — | 3.57M | HC, IN | — | 2022-02-11 | ↗ |
| 17 | Averill Master Fund, Ltd. | 3.57M | 5.40% | — | 3.57M | — | 3.57M | CO | — | 2022-02-11 | ↗ |
| 18 | Suvretta Capital Management, LLC | 3.57M | 5.40% | — | 3.57M | — | 3.57M | IA, OO | — | 2022-02-11 | ↗ |
| 19 | BVF Inc. | 3.55M | 5.30% | — | — | — | 3.55M | CO | Delaware | 2022-12-05 | ↗ |
| 20 | BVF Partners L.P. | 3.55M | 5.30% | — | — | — | 3.55M | IA, PN | Delaware | 2022-12-05 | ↗ |
| 21 | Mark N. Lampert | 3.55M | 5.30% | — | — | — | 3.55M | IN | Delaware | 2022-12-05 | ↗ |
| 22 | Company, L.P. | 3.51M | 5.28% | — | 3.51M | — | — | PN | Delaware | 2021-12-03 | ↗ |
| 23 | STATE STREET CORPORATION | 3.38M | 5.08% | — | 3.26M | — | 3.38M | HC | — | 2022-02-11 | ↗ |
| 24 | David Kroin | 3.36M | 5.05% | — | 3.36M | — | — | HC, IN | United States | 2022-02-04 | ↗ |
| 25 | Deep Track Biotechnology Master Fund, Ltd. | 3.36M | 5.05% | — | 3.36M | — | — | CO | United States | 2022-02-04 | ↗ |
| 26 | Deep Track Capital, LP | 3.36M | 5.05% | — | 3.36M | — | — | IA, OO | United States | 2022-02-04 | ↗ |
| 27 | BVF GP Holdings LLC | 3.33M | 5.00% | — | — | — | 3.33M | OO | Delaware | 2022-12-05 | ↗ |
| 28 | Troy Edward Wilson | 2.19M | 3.30% | 570.4K | 1.62M | 570.4K | — | IN | United States | 2021-01-28 | ↗ |
| 29 | BVF I GP LLC | 1.83M | 2.70% | — | — | — | 1.83M | OO | Delaware | 2022-12-05 | ↗ |
| 30 | Biotechnology Value Fund, L.P. | 1.83M | 2.70% | — | — | — | 1.83M | PN | Delaware | 2022-12-05 | ↗ |
| 31 | BVF II GP LLC | 1.50M | 2.30% | — | — | — | 1.50M | OO | Delaware | 2022-12-05 | ↗ |
| 32 | Biotechnology Value Fund II, L.P. | 1.50M | 2.30% | — | — | — | 1.50M | PN | Delaware | 2022-12-05 | ↗ |
| 33 | BVF Partners OS Ltd. | 161.4K | 1.00% | — | — | — | 161.4K | CO | Delaware | 2022-12-05 | ↗ |
| 34 | Biotechnology Value Trading Fund OS LP | 161.4K | 1.00% | — | — | — | 161.4K | PN | Delaware | 2022-12-05 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
54
-165 vs prev Q
New positions
8
Closed positions
164
Increased
27
Reduced
20
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | BLACKROCK, INC. | 9.01M -504.3K (-5.3%) | 93.62M +9.4M (+11.2%) | 10.28% -0.583 pp | 0.00% +0.000 pp | USD16.40 -36.6% | 6 qtrs — |
| 2 | BVF INC/IL | 8.62M +— (+0.0%) | 89.53M +13.3M (+17.4%) | 9.83% -0.007 pp | 3.01% -0.078 pp | USD9.15 +13.6% | 34 qtrs — |
| 3 | SUVRETTA CAPITAL MANAGEMENT, LLC | 8.58M +459.4K (+5.7%) | 89.10M +17.3M (+24.0%) | 9.78% +0.518 pp | 1.83% -0.013 pp | USD12.59 -17.5% | 22 qtrs — |
| 4 | VANGUARD GROUP INC | 5.51M +39.1K (+0.7%) | 57.22M +8.8M (+18.2%) | 6.28% +0.040 pp | 0.00% +0.000 pp | USD14.96 -30.5% | 41 qtrs — |
| 5 | ARMISTICE CAPITAL, LLC | 4.94M +264.0K (+5.7%) | 51.29M +9.9M (+24.0%) | 5.63% +0.298 pp | 0.61% -0.003 pp | USD10.41 -0.2% | 13 qtrs — |
| 6 | STATE STREET CORP | 4.93M +1.6M (+47.5%) | 51.23M +21.6M (+73.2%) | 5.63% +1.809 pp | 0.00% +0.001 pp | USD14.60 -28.8% | 35 qtrs — |
| 7 | AQR CAPITAL MANAGEMENT LLC | 3.06M +820.0K (+36.6%) | 31.82M +12.0M (+60.3%) | 3.49% +0.934 pp | 0.02% +0.004 pp | USD9.01 +15.3% | 11 qtrs — |
| 8 | PROSIGHT MANAGEMENT, LP | 2.53M -228.9K (-8.3%) | 26.28M +1.9M (+7.7%) | 2.89% -0.263 pp | 5.43% -0.263 pp | USD7.75 +34.1% | 11 qtrs — |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 2.03M -19.3K (-0.9%) | 21.08M +3.0M (+16.3%) | 2.31% -0.024 pp | 0.00% +0.000 pp | USD15.93 -34.8% | 38 qtrs — |
| 10 | JACOBS LEVY EQUITY MANAGEMENT, INC | 2.02M -202.3K (-9.1%) | 21.01M +1.3M (+6.7%) | 2.31% -0.233 pp | 0.08% +0.003 pp | USD8.40 +23.7% | 5 qtrs — |
| 11 | GOLDMAN SACHS GROUP INC | 1.84M -777.5K (-29.7%) | 19.09M -4.1M (-17.5%) | 2.10% -0.889 pp | 0.00% -0.001 pp | USD11.26 -7.7% | 36 qtrs — |
| 12 | RENAISSANCE TECHNOLOGIES LLC | 1.83M +965.3K (+111.6%) | 19.02M +11.4M (+148.4%) | 2.09% +1.101 pp | 0.03% +0.019 pp | USD9.08 +14.4% | 19 qtrs — |
| 13 | MILLENNIUM MANAGEMENT LLC | 1.58M -509.3K (-24.3%) | 16.46M -2.1M (-11.2%) | 1.81% -0.583 pp | 0.01% -0.001 pp | USD10.40 -0.1% | 36 qtrs — |
| 14 | ALETHEA CAPITAL MANAGEMENT, LLC | 1.42M +33.9K (+2.4%) | 14.78M +2.5M (+20.3%) | 1.62% +0.038 pp | 7.18% -0.719 pp | USD11.50 -9.7% | 17 qtrs — |
| 15 | MORGAN STANLEY | 1.39M -423.2K (-23.3%) | 14.44M -1.6M (-10.0%) | 1.59% -0.484 pp | 0.00% 0.000 pp | USD10.75 -3.3% | 39 qtrs — |
| 16 | QUBE RESEARCH & TECHNOLOGIES LTD | 1.33M -379.2K (-22.1%) | 13.86M -1.3M (-8.6%) | 1.52% -0.434 pp | 0.01% -0.002 pp | USD8.09 +28.4% | 13 qtrs — |
| 17 | ASSENAGON ASSET MANAGEMENT S.A. | 1.15M -120.0K (-9.5%) | 11.90M +701.2K (+6.3%) | 1.31% -0.138 pp | 0.02% +0.001 pp | USD16.02 -35.1% | 22 qtrs — |
| 18 | AMERICAN CENTURY COMPANIES INC | 1.12M +448.0K (+67.0%) | 11.61M +5.7M (+96.0%) | 1.27% +0.511 pp | 0.01% +0.003 pp | USD9.21 +12.8% | 14 qtrs — |
| 19 | DIMENSIONAL FUND ADVISORS LP | 1.08M -61.5K (-5.4%) | 11.20M +1.1M (+11.0%) | 1.23% -0.071 pp | 0.00% +0.000 pp | USD14.77 -29.7% | 29 qtrs — |
| 20 | UBS GROUP AG | 1.06M +574.5K (+118.3%) | 11.01M +6.7M (+156.3%) | 1.21% +0.655 pp | 0.00% +0.001 pp | USD9.95 +4.4% | 40 qtrs — |
| 21 | NAN FUNG TRINITY (HK) LTD | 964.9K +734.0K (+317.9%) | 10.03M +8.0M (+390.6%) | 1.10% +0.837 pp | 0.79% +0.590 pp | USD10.02 +3.7% | 2 qtrs — |
| 22 | ACADIAN ASSET MANAGEMENT LLC | 886.6K -174.3K (-16.4%) | 9.21M -177.0K (-1.9%) | 1.01% -0.200 pp | 0.02% -0.001 pp | USD6.58 +57.9% | 4 qtrs — |
| 23 | RHENMAN & PARTNERS ASSET MANAGEMENT AB | 872.0K +382.0K (+78.0%) | 9.06M +4.7M (+108.9%) | 0.99% +0.436 pp | 0.85% +0.367 pp | USD10.85 -4.2% | 8 qtrs — |
| 24 | BANK OF AMERICA CORP /DE/ | 842.1K +270.0K (+47.2%) | 8.75M +3.7M (+72.8%) | 0.96% +0.308 pp | 0.00% +0.000 pp | USD10.64 -2.3% | 34 qtrs — |
| 25 | NORTHERN TRUST CORP | 723.2K -30.4K (-4.0%) | 7.51M +844.9K (+12.7%) | 0.83% -0.035 pp | 0.00% +0.000 pp | USD14.57 -28.7% | 38 qtrs — |
| 26 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 710.9K -1.0K (-0.1%) | 7.39M +1.1M (+17.2%) | 0.81% -0.002 pp | 0.00% +0.000 pp | USD16.36 -36.5% | 35 qtrs — |
| 27 | CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 618.6K +253.6K (+69.5%) | 6.43M +3.2M (+99.0%) | 0.71% +0.289 pp | 0.02% +0.007 pp | USD9.48 +9.6% | 2 qtrs — |
| 28 | JANE STREET GROUP, LLC | 477.1K +231.3K (+94.1%) | 4.96M +2.8M (+127.9%) | 0.54% +0.264 pp | 0.00% +0.000 pp | USD11.03 -5.8% | 22 qtrs — |
| 29 | FISHER ASSET MANAGEMENT, LLC | 472.0K +472.0K (+100.0%) | 4.90M +4.9M (+100.0%) | 0.54% +0.539 pp | 0.00% +0.002 pp | USD10.39 +0.0% | 1 qtrs NEW |
| 30 | TWO SIGMA INVESTMENTS, LP | 471.8K +267.1K (+130.5%) | 4.90M +3.1M (+170.6%) | 0.54% +0.305 pp | 0.01% +0.004 pp | USD11.91 -12.8% | 8 qtrs — |
| 31 | SECTOR GAMMA AS | 455.8K +17.4K (+4.0%) | 4.74M +856.2K (+22.1%) | 0.52% +0.020 pp | 1.08% +0.118 pp | USD8.91 +16.6% | 2 qtrs — |
| 32 | 1492 CAPITAL MANAGEMENT LLC | 452.6K +7.0K (+1.6%) | 4.70M +759.0K (+19.2%) | 0.52% +0.008 pp | 1.80% +0.206 pp | USD9.31 +11.6% | 15 qtrs — |
| 33 | PALE FIRE CAPITAL SE | 452.2K -155.5K (-25.6%) | 4.70M -680.1K (-12.6%) | 0.52% -0.178 pp | 0.32% -0.273 pp | USD8.75 +18.7% | 3 qtrs — |
| 34 | JUMP FINANCIAL, LLC | 422.4K +389.6K (+1,188.2%) | 4.39M +4.1M (+1,412.3%) | 0.48% +0.445 pp | 0.05% +0.050 pp | USD10.35 +0.4% | 14 qtrs — |
| 35 | IEQ CAPITAL, LLC | 398.5K +124.4K (+45.4%) | 4.14M +1.7M (+70.7%) | 0.45% +0.142 pp | 0.01% +0.005 pp | USD8.43 +23.3% | 4 qtrs — |
| 36 | BARCLAYS PLC | 394.6K +229.1K (+138.5%) | 4.10M +866.4K (+26.8%) | 0.45% +0.261 pp | 0.00% +0.000 pp | USD10.42 -0.3% | 36 qtrs — |
| 37 | SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 392.8K +48.9K (+14.2%) | 4.08M +1.0M (+34.1%) | 0.45% +0.056 pp | 0.06% +0.015 pp | USD9.04 +14.9% | 2 qtrs — |
| 38 | CITADEL ADVISORS LLC | 390.7K -418.1K (-51.7%) | 4.06M -3.1M (-43.3%) | 0.45% -0.478 pp | 0.00% -0.001 pp | USD14.24 -27.0% | 31 qtrs — |
| 39 | GREAT LAKES ADVISORS, LLC | 390.2K +390.2K (+100.0%) | 4.05M +4.1M (+100.0%) | 0.45% +0.445 pp | 0.03% +0.033 pp | USD10.39 +0.0% | 1 qtrs NEW |
| 40 | AMERIPRISE FINANCIAL INC | 346.7K +19.1K (+5.8%) | 3.60M +703.0K (+24.3%) | 0.40% +0.022 pp | 0.00% +0.000 pp | USD8.93 +16.3% | 7 qtrs — |
| 41 | FMR LLC | 306.6K +219.7K (+252.9%) | 3.19M +2.4M (+314.3%) | 0.35% +0.251 pp | 0.00% +0.000 pp | USD9.79 +6.1% | 41 qtrs — |
| 42 | SPHERA FUNDS MANAGEMENT LTD. | 295.5K +50.0K (+20.4%) | 3.07M +897.6K (+41.3%) | 0.34% +0.057 pp | 0.59% +0.135 pp | USD15.72 -33.9% | 23 qtrs — |
| 43 | HENNION & WALSH ASSET MANAGEMENT, INC. | 294.8K +80.0K (+37.2%) | 3.06M +1.2M (+61.1%) | 0.34% +0.091 pp | 0.11% +0.037 pp | USD11.94 -13.0% | 15 qtrs — |
| 44 | FRANKLIN RESOURCES INC | 281.1K +52.7K (+23.1%) | 2.92M +899.1K (+44.5%) | 0.32% +0.060 pp | 0.00% +0.000 pp | USD18.26 -43.1% | 21 qtrs — |
| 45 | BANK OF NEW YORK MELLON CORP | 258.4K +3.2K (+1.2%) | 2.69M +426.2K (+18.9%) | 0.29% +0.003 pp | 0.00% +0.000 pp | USD15.52 -33.1% | 35 qtrs — |
| 46 | MAN GROUP PLC | 241.5K -216.7K (-47.3%) | 2.51M -1.5M (-38.1%) | 0.28% -0.248 pp | 0.00% -0.003 pp | USD6.09 +70.6% | 5 qtrs — |
| 47 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 241.1K +241.1K (+100.0%) | 2.50M +2.5M (+100.0%) | 0.28% +0.275 pp | 0.01% +0.009 pp | USD10.39 +0.0% | 1 qtrs NEW |
| 48 | DAFNA CAPITAL MANAGEMENT LLC | 235.9K -227.5K (-49.1%) | 2.45M -1.7M (-40.2%) | 0.27% -0.260 pp | 0.57% -0.444 pp | USD11.42 -9.0% | 34 qtrs — |
| 49 | TREXQUANT INVESTMENT LP | 227.4K +12.3K (+5.7%) | 2.36M +459.4K (+24.1%) | 0.26% +0.014 pp | 0.02% +0.002 pp | USD9.22 +12.7% | 11 qtrs — |
| 50 | DEKABANK DEUTSCHE GIROZENTRALE | 95.0K +— (+0.0%) | 2.19M +1.3M (+160.4%) | 0.11% 0.000 pp | 0.00% +0.002 pp | USD12.72 -18.3% | 10 qtrs — |
| 51 | INVESCO LTD. | 209.4K +26.7K (+14.6%) | 2.18M +558.6K (+34.5%) | 0.24% +0.030 pp | 0.00% +0.000 pp | USD12.18 -14.7% | 22 qtrs — |
| 52 | CREATIVE PLANNING | 198.8K +21.7K (+12.3%) | 2.07M +498.4K (+31.8%) | 0.23% +0.025 pp | 0.00% +0.000 pp | USD7.55 +37.6% | 5 qtrs — |
| 53 | RAFFERTY ASSET MANAGEMENT, LLC | 187.4K +74.2K (+65.5%) | 1.95M +945.0K (+94.3%) | 0.21% +0.085 pp | 0.01% +0.004 pp | USD12.80 -18.8% | 28 qtrs — |
| 54 | DARK FOREST CAPITAL MANAGEMENT LP | 183.5K +183.5K (+100.0%) | 1.91M +1.9M (+100.0%) | 0.21% +0.209 pp | 0.09% +0.087 pp | USD10.39 +0.0% | 1 qtrs NEW |
| 55 | SEI INVESTMENTS CO | 183.4K +183.4K (+100.0%) | 1.91M +1.9M (+100.0%) | 0.21% +0.209 pp | 0.00% +0.002 pp | USD10.39 +0.0% | 1 qtrs NEW |
| 56 | MOODY ALDRICH PARTNERS LLC | 179.7K +179.7K (+100.0%) | 1.87M +1.9M (+100.0%) | 0.21% +0.205 pp | 0.35% +0.349 pp | USD10.39 +0.0% | 1 qtrs NEW |
| 57 | RUSSELL INVESTMENTS GROUP, LTD. | 160.0K -167.9K (-51.2%) | 1.66M -1.2M (-42.7%) | 0.18% -0.192 pp | 0.00% -0.002 pp | USD13.58 -23.5% | 21 qtrs — |
| 58 | CWM, LLC | 156.5K +38.2K (+32.3%) | 1.63M +578.0K (+55.2%) | 0.18% +0.044 pp | 0.00% +0.001 pp | USD8.69 +19.6% | 7 qtrs — |
| 59 | TWO SIGMA ADVISERS, LP | 152.6K +26.4K (+20.9%) | 1.59M +468.6K (+42.0%) | 0.17% +0.030 pp | 0.00% +0.001 pp | USD10.27 +1.2% | 31 qtrs — |
| 60 | SG AMERICAS SECURITIES, LLC | 151.7K +103.4K (+214.1%) | 1.58M +1.1M (+269.1%) | 0.17% +0.118 pp | 0.00% +0.001 pp | USD9.90 +4.9% | 5 qtrs — |
| 61 | NUVEEN, LLC | 151.1K -248.7K (-62.2%) | 1.57M -2.0M (-55.6%) | 0.17% -0.284 pp | 0.00% -0.001 pp | USD6.26 +66.0% | 4 qtrs — |
| 62 | WOODLINE PARTNERS LP | 145.7K +— (+0.0%) | 1.51M +224.4K (+17.4%) | 0.17% 0.000 pp | 0.01% 0.000 pp | USD19.07 -45.5% | 7 qtrs — |
| 63 | SWISS NATIONAL BANK | 145.6K +11.3K (+8.4%) | 1.51M +324.2K (+27.3%) | 0.17% +0.013 pp | 0.00% +0.000 pp | USD14.20 -26.8% | 31 qtrs — |
| 64 | CERITY PARTNERS LLC | 134.3K +40.5K (+43.1%) | 1.40M +565.0K (+68.0%) | 0.15% +0.046 pp | 0.00% +0.001 pp | USD8.23 +26.2% | 4 qtrs — |
| 65 | PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | 133.4K +8.5K (+6.8%) | 1.39M +280.2K (+25.4%) | 0.15% +0.010 pp | 0.00% +0.001 pp | USD8.95 +16.1% | 2 qtrs — |
| 66 | MARINER, LLC | 125.9K +63.9K (+103.1%) | 1.31M +757.3K (+138.0%) | 0.14% +0.073 pp | 0.00% +0.001 pp | USD9.44 +10.1% | 4 qtrs — |
| 67 | XCEL WEALTH MANAGEMENT, LLC | 118.8K +16.5K (+16.2%) | 1.23M +329.3K (+36.4%) | 0.14% +0.019 pp | 0.31% +0.079 pp | USD9.06 +14.7% | 2 qtrs — |
| 68 | UBS ASSET MANAGEMENT AMERICAS INC | 106.9K -3.9K (-3.5%) | 1.11M +130.3K (+13.3%) | 0.12% -0.005 pp | 0.00% +0.000 pp | USD14.74 -29.5% | 26 qtrs — |
| 69 | WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 115.3K +24.3K (+26.6%) | 1.10M +241.4K (+28.1%) | 0.13% +0.028 pp | 0.00% +0.000 pp | USD7.81 +33.0% | 4 qtrs — |
| 70 | RHUMBLINE ADVISERS | 104.4K -15.5K (-12.9%) | 1.09M +23.8K (+2.2%) | 0.12% -0.018 pp | 0.00% +0.000 pp | USD14.85 -30.0% | 35 qtrs — |
| 71 | RANGELEY CAPITAL, LLC | 102.9K -17.1K (-14.3%) | 1.07M +7.1K (+0.7%) | 0.12% -0.020 pp | 0.89% -0.031 pp | USD5.87 +77.0% | 3 qtrs — |
| 72 | ROSALIND ADVISORS, INC. | 100.0K +— (+0.0%) | 1.04M +154.0K (+17.4%) | 0.11% 0.000 pp | 0.37% +0.063 pp | USD6.60 +57.4% | 4 qtrs — |
| 73 | HRT FINANCIAL LP | 98.0K -270.5K (-73.4%) | 1.02M -2.2M (-68.8%) | 0.11% -0.309 pp | 0.00% -0.009 pp | USD7.46 +39.3% | 9 qtrs — |
| 74 | PRUDENTIAL FINANCIAL INC | 92.2K +8.5K (+10.1%) | 958.0K +216.8K (+29.2%) | 0.11% +0.010 pp | 0.00% +0.000 pp | USD8.99 +15.6% | 2 qtrs — |
| 75 | WELLS FARGO & COMPANY/MN | 91.5K +28.7K (+45.7%) | 950.8K +394.8K (+71.0%) | 0.10% +0.033 pp | 0.00% +0.000 pp | USD10.54 -1.4% | 34 qtrs — |
| 76 | POLEN CAPITAL MANAGEMENT LLC | 90.8K +90.8K (+100.0%) | 943.9K +943.9K (+100.0%) | 0.10% +0.104 pp | 0.00% +0.004 pp | USD10.39 +0.0% | 1 qtrs NEW |
| 77 | GSA CAPITAL PARTNERS LLP | 88.4K -29.2K (-24.8%) | 918.0K -123.0K (-11.8%) | 0.10% -0.033 pp | 0.08% -0.008 pp | USD6.37 +63.1% | 5 qtrs — |
| 78 | ALLIANCEBERNSTEIN L.P. | 84.8K +— (+0.0%) | 881.1K +130.6K (+17.4%) | 0.10% 0.000 pp | 0.00% +0.000 pp | USD13.38 -22.3% | 32 qtrs — |
| 79 | DEUTSCHE BANK AG\ | 80.8K +2.8K (+3.5%) | 839.6K +148.9K (+21.6%) | 0.09% +0.003 pp | 0.00% +0.000 pp | USD11.47 -9.4% | 39 qtrs — |
| 80 | LEGAL & GENERAL GROUP PLC | 78.3K -92.0 (-0.1%) | 813.1K +119.7K (+17.3%) | 0.09% 0.000 pp | 0.00% +0.000 pp | USD11.83 -12.2% | 35 qtrs — |
| 81 | STATE OF WISCONSIN INVESTMENT BOARD | 75.7K +11.2K (+17.3%) | 786.5K +215.3K (+37.7%) | 0.09% +0.013 pp | 0.00% +0.000 pp | USD6.45 +61.1% | 35 qtrs — |
| 82 | ACT CAPITAL MANAGEMENT, LLC | 73.9K +73.9K (+100.0%) | 767.8K +767.8K (+100.0%) | 0.08% +0.084 pp | 0.62% +0.621 pp | USD10.39 +0.0% | 1 qtrs NEW |
| 83 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 72.1K +6.2K (+9.4%) | 748.6K +165.7K (+28.4%) | 0.08% +0.007 pp | 0.00% +0.000 pp | USD13.96 -25.6% | 35 qtrs — |
| 84 | ALPS ADVISORS INC | 71.4K +32.5K (+83.3%) | 742.3K +397.3K (+115.2%) | 0.08% +0.037 pp | 0.00% +0.002 pp | USD7.87 +32.0% | 3 qtrs — |
| 85 | PROFUND ADVISORS LLC | 69.1K +44.3K (+178.3%) | 718.2K +498.4K (+226.8%) | 0.08% +0.051 pp | 0.02% +0.015 pp | USD11.50 -9.7% | 12 qtrs — |
| 86 | AARON WEALTH ADVISORS LLC | 67.1K -4.0 (0.0%) | 697.6K +103.4K (+17.4%) | 0.08% 0.000 pp | 0.04% +0.003 pp | USD17.49 -40.6% | 21 qtrs — |
| 87 | VIRTUS INVESTMENT ADVISERS, INC. | 66.9K +49.8K (+291.4%) | 694.8K +543.6K (+359.5%) | 0.08% +0.057 pp | 0.19% +0.146 pp | USD9.52 +9.1% | 4 qtrs — |
| 88 | GROUP ONE TRADING, L.P. | 65.0K -11.6K (-15.2%) | 675.5K -2.7K (-0.4%) | 0.07% -0.013 pp | 0.00% +0.000 pp | USD8.85 +17.4% | 2 qtrs — |
| 89 | SQUAREPOINT OPS LLC | 64.7K +64.7K (+100.0%) | 672.0K +672.0K (+100.0%) | 0.07% +0.074 pp | 0.00% +0.001 pp | USD10.39 +0.0% | 33 qtrs — |
| 90 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 63.5K -100.8K (-61.4%) | 659.8K -794.3K (-54.6%) | 0.07% -0.115 pp | 0.00% 0.000 pp | USD8.85 +17.4% | 18 qtrs — |
| 91 | SECTORAL ASSET MANAGEMENT INC | 54.1K -341.8K (-86.3%) | 562.2K -2.9M (-84.0%) | 0.06% -0.390 pp | 0.45% -1.712 pp | USD6.33 +64.1% | 3 qtrs — |
| 92 | HSBC HOLDINGS PLC | 52.0K -79.2K (-60.4%) | 536.2K -613.1K (-53.3%) | 0.06% -0.091 pp | 0.00% 0.000 pp | USD7.05 +47.4% | 10 qtrs — |
| 93 | MERCER GLOBAL ADVISORS INC /ADV | 50.1K +17.2K (+52.3%) | 520.3K +229.3K (+78.8%) | 0.06% +0.020 pp | 0.00% +0.000 pp | USD9.38 +10.8% | 2 qtrs — |
| 94 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 48.4K +5.4K (+12.7%) | 500.7K +120.0K (+31.5%) | 0.06% +0.006 pp | 0.00% +0.000 pp | USD18.33 -43.3% | 7 qtrs — |
| 95 | ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 46.4K +13.6K (+41.4%) | 481.7K +191.6K (+66.0%) | 0.05% +0.016 pp | 0.00% +0.000 pp | USD12.08 -14.0% | 29 qtrs — |
| 96 | LION POINT CAPITAL, LP | 46.0K +— (+0.0%) | 477.9K +70.8K (+17.4%) | 0.05% +0.000 pp | 2.47% +0.161 pp | USD8.85 +17.4% | 2 qtrs — |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
1.00
Neutral
Ratio by volume
3.00
Bullish
Buys
16
Sells
16
Shares acquired
2.00M
Shares disposed
36.1K
Cash buys
—
Cash sales
16.00
Net activity
+1,964,888
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-23 | WILSON TROY EDWARD | Director / Officer | M-Exempt | A | Common Stock | 6,103 | 6.15 | 37.5K | 435,456 | D | ↗ |
| 2026-03-18 | Malley Thomas | Director | M-Exempt | A | Common Stock | 10,000 | 3.12 | 31.2K | 10,000 | D | ↗ |
| 2026-01-27 | Powl Brian T. | Officer | S-Sale | D | Common Stock | 1,572 | 8.46 | 13.3K | 183,275 | D | ↗ |
| 2026-01-27 | Leoni Mollie | Officer | S-Sale | D | Common Stock | 1,341 | 8.46 | 11.3K | 267,274 | D | ↗ |
| 2026-01-27 | FORD KATHLEEN | Officer | S-Sale | D | Common Stock | 1,813 | 8.46 | 15.3K | 153,560 | D | ↗ |
| 2026-01-27 | DOYLE THOMAS JAMES | Officer | S-Sale | D | Common Stock | 2,226 | 8.46 | 18.8K | 150,083 | D | ↗ |
| 2026-01-27 | Burrows Francis | Officer | S-Sale | D | Common Stock | 1,311 | 8.46 | 11.1K | 32,424 | D | ↗ |
| 2026-01-27 | Bair Teresa Brophy | Officer | S-Sale | D | Common Stock | 4,777 | 8.46 | 40.4K | 226,931 | D | ↗ |
| 2026-01-02 | WILSON TROY EDWARD | Director / Officer | A-Award | A | Option to purchase common stock | 1,120,000 | 10.34 | 11.58M | 1,120,000 | D | ↗ |
| 2026-01-02 | Powl Brian T. | Officer | A-Award | A | Option to purchase common stock | 100,000 | 10.34 | 1.03M | 100,000 | D | ↗ |
| 2026-01-02 | Leoni Mollie | Officer | A-Award | A | Option to purchase common stock | 100,000 | 10.34 | 1.03M | 100,000 | D | ↗ |
| 2026-01-02 | FORD KATHLEEN | Officer | A-Award | A | Common Stock | 50,000 | 0.00 | — | 155,373 | D | ↗ |
| 2026-01-02 | DOYLE THOMAS JAMES | Officer | A-Award | A | Option to purchase common stock | 42,500 | 10.34 | 439.2K | 42,500 | D | ↗ |
| 2026-01-02 | Burrows Francis | Officer | A-Award | A | Option to purchase common stock | 185,000 | 10.34 | 1.91M | 185,000 | D | ↗ |
| 2026-01-02 | Bair Teresa Brophy | Officer | A-Award | A | Option to purchase common stock | 100,000 | 10.34 | 1.03M | 100,000 | D | ↗ |
| 2025-12-18 | Burrows Francis | Officer | S-Sale | D | Common Stock | 23,726 | 9.78 | 231.9K | 33,735 | D | ↗ |
| 2025-12-09 | Hasnain Faheem | Director | M-Exempt | A | Common Stock | 10,000 | 3.12 | 31.2K | 33,983 | D | ↗ |
| 2025-11-14 | Powl Brian T. | Officer | S-Sale | D | Common Stock | 8,887 | 11.18 | 99.3K | 139,689 | D | ↗ |
| 2025-11-14 | Leoni Mollie | Officer | S-Sale | D | Common Stock | 15,485 | 11.18 | 173.1K | 225,454 | D | ↗ |
| 2025-11-14 | FORD KATHLEEN | Officer | S-Sale | D | Common Stock | 6,902 | 11.18 | 77.1K | 105,373 | D | ↗ |
| 2025-11-14 | DOYLE THOMAS JAMES | Officer | S-Sale | D | Common Stock | 4,539 | 11.18 | 50.7K | 130,257 | D | ↗ |
| 2025-11-14 | Bair Teresa Brophy | Officer | S-Sale | D | Common Stock | 8,804 | 11.18 | 98.4K | 188,139 | D | ↗ |
| 2025-11-13 | WILSON TROY EDWARD | Director / Officer | A-Award | A | Common Stock | 182,500 | 0.00 | — | 429,353 | D | ↗ |
| 2025-11-13 | Powl Brian T. | Officer | A-Award | A | Common Stock | 48,900 | 0.00 | — | 148,576 | D | ↗ |
| 2025-11-13 | Leoni Mollie | Officer | A-Award | A | Common Stock | 82,500 | 0.00 | — | 240,939 | D | ↗ |
| 2025-11-13 | FORD KATHLEEN | Officer | A-Award | A | Common Stock | 48,900 | 0.00 | — | 112,275 | D | ↗ |
| 2025-11-13 | DOYLE THOMAS JAMES | Officer | A-Award | A | Common Stock | 24,967 | 0.00 | — | 134,796 | D | ↗ |
| 2025-11-13 | Bair Teresa Brophy | Officer | A-Award | A | Common Stock | 48,900 | 0.00 | — | 196,943 | D | ↗ |
| 2025-09-29 | WILSON TROY EDWARD | Director / Officer | S-Sale | D | Common Stock | 36,615 | 8.94 | 327.4K | 246,853 | D | ↗ |
| 2025-09-29 | Powl Brian T. | Officer | S-Sale | D | Common Stock | 8,891 | 8.94 | 79.5K | 99,676 | D | ↗ |
| 2025-09-29 | Leoni Mollie | Officer | S-Sale | D | Common Stock | 12,314 | 8.94 | 110.1K | 158,439 | D | ↗ |
| 2025-09-29 | FORD KATHLEEN | Officer | S-Sale | D | Common Stock | 6,892 | 8.94 | 61.6K | 63,375 | D | ↗ |
| 2025-09-29 | DOYLE THOMAS JAMES | Officer | S-Sale | D | Common Stock | 4,541 | 8.94 | 40.6K | 109,829 | D | ↗ |
| 2025-09-29 | Bair Teresa Brophy | Officer | S-Sale | D | Common Stock | 8,805 | 8.94 | 78.7K | 148,043 | D | ↗ |
| 2025-09-27 | WILSON TROY EDWARD | Director / Officer | A-Award | A | Common Stock | 182,500 | 0.00 | — | 283,468 | D | ↗ |
| 2025-09-27 | Powl Brian T. | Officer | A-Award | A | Common Stock | 48,900 | 0.00 | — | 108,567 | D | ↗ |
| 2025-09-27 | Leoni Mollie | Officer | A-Award | A | Common Stock | 82,500 | 0.00 | — | 170,753 | D | ↗ |
| 2025-09-27 | FORD KATHLEEN | Officer | A-Award | D | Common Stock | 48,900 | 0.00 | — | 70,267 | D | ↗ |
| 2025-09-27 | DOYLE THOMAS JAMES | Officer | A-Award | A | Common Stock | 24,966 | 0.00 | — | 114,370 | D | ↗ |
| 2025-09-27 | Bair Teresa Brophy | Officer | A-Award | A | Common Stock | 48,900 | 0.00 | — | 156,848 | D | ↗ |
| 2025-09-08 | WILSON TROY EDWARD | Director / Officer | P-Purchase | A | Common Stock | 50,000 | 8.20 | 410.1K | 100,968 | D | ↗ |
| 2025-08-13 | WILSON TROY EDWARD | Director / Officer | P-Purchase | A | Common Stock | 13,494 | 6.64 | 89.6K | 50,968 | D | ↗ |
| 2025-08-12 | WILSON TROY EDWARD | Director / Officer | P-Purchase | A | Common Stock | 36,506 | 5.85 | 213.6K | 37,474 | D | ↗ |
| 2025-06-05 | VASCONCELLES MICHAEL | Director | A-Award | A | Option to purchase common stock | 28,500 | 6.57 | 187.2K | 28,500 | D | ↗ |
| 2025-06-05 | Szela Mary T | Director | A-Award | A | Option to purchase common stock | 28,500 | 6.57 | 187.2K | 28,500 | D | ↗ |
| 2025-06-05 | SCHAFER CAROL | Director | A-Award | A | Option to purchase common stock | 28,500 | 6.57 | 187.2K | 28,500 | D | ↗ |
| 2025-06-05 | Parks Diane L. | Director | A-Award | A | Option to purchase common stock | 28,500 | 6.57 | 187.2K | 28,500 | D | ↗ |
| 2025-06-05 | Malley Thomas | Director | A-Award | A | Option to purchase common stock | 28,500 | 6.57 | 187.2K | 28,500 | D | ↗ |
| 2025-06-05 | Hasnain Faheem | Director | A-Award | A | Option to purchase common stock | 28,500 | 6.57 | 187.2K | 28,500 | D | ↗ |
| 2025-06-05 | Collins Helen Louise | Director | A-Award | A | Option to purchase common stock | 28,500 | 6.57 | 187.2K | 28,500 | D | ↗ |
| 2025-05-19 | FORD KATHLEEN | Officer | S-Sale | D | Common Stock | 1,558 | 6.28 | 9.8K | 21,367 | D | ↗ |
| 2025-05-19 | Bair Teresa Brophy | Officer | S-Sale | D | Common Stock | 1,559 | 5.96 | 9.3K | 107,948 | D | ↗ |
| 2025-03-21 | Hasnain Faheem | Director | M-Exempt | A | Common Stock | 22,682 | 6.32 | 143.4K | 46,665 | D | ↗ |
| 2025-01-28 | Powl Brian T. | Officer | S-Sale | D | Common Stock | 1,583 | 7.87 | 12.5K | 59,667 | D | ↗ |
| 2025-01-28 | Leoni Mollie | Officer | S-Sale | D | Common Stock | 541 | 7.87 | 4.3K | 88,253 | D | ↗ |
| 2025-01-28 | FORD KATHLEEN | Officer | S-Sale | D | Common Stock | 1,817 | 7.87 | 14.3K | 21,367 | D | ↗ |
| 2025-01-28 | DOYLE THOMAS JAMES | Officer | S-Sale | D | Common Stock | 1,122 | 7.87 | 8.8K | 88,193 | D | ↗ |
| 2025-01-28 | Burrows Francis | Officer | S-Sale | D | Common Stock | 1,320 | 7.87 | 10.4K | 20,705 | D | ↗ |
| 2025-01-28 | Bair Teresa Brophy | Officer | S-Sale | D | Common Stock | 4,844 | 7.87 | 38.1K | 107,948 | D | ↗ |
| 2025-01-02 | WILSON TROY EDWARD | Director / Officer | A-Award | A | Option to purchase common stock | 625,000 | 8.68 | 5.43M | 625,000 | D | ↗ |
| 2025-01-02 | Powl Brian T. | Officer | A-Award | A | Option to purchase common stock | 92,500 | 8.68 | 802.9K | 92,500 | D | ↗ |
| 2025-01-02 | Leoni Mollie | Officer | — | — | Option to purchase common stock | 52,500 | 14.15 | 742.9K | 0 | D | ↗ |
| 2025-01-02 | FORD KATHLEEN | Officer | A-Award | A | Option to purchase common stock | 185,000 | 8.68 | 1.61M | 185,000 | D | ↗ |
| 2025-01-02 | DOYLE THOMAS JAMES | Officer | A-Award | A | Option to purchase common stock | 42,500 | 8.68 | 368.9K | 42,500 | D | ↗ |
| 2025-01-02 | Burrows Francis | Officer | — | — | Option to purchase common stock | 26,565 | 11.86 | 315.1K | 0 | D | ↗ |
| 2025-01-02 | Bair Teresa Brophy | Officer | A-Award | A | Common Stock | 46,250 | 0.00 | — | 115,229 | D | ↗ |
| 2024-11-18 | FORD KATHLEEN | Officer | S-Sale | D | Common Stock | 526 | 16.03 | 8.4K | 23,184 | D | ↗ |
| 2024-09-13 | VASCONCELLES MICHAEL | Director | A-Award | A | Option to purchase common stock | 52,000 | 20.88 | 1.09M | 52,000 | — | ↗ |
| 2024-06-05 | Szela Mary T | Director | A-Award | A | Option to purchase common stock | 26,000 | 21.79 | 566.5K | 26,000 | — | ↗ |
| 2024-06-05 | SCHAFER CAROL | Director | A-Award | A | Option to purchase common stock | 26,000 | 21.79 | 566.5K | 26,000 | — | ↗ |
| 2024-06-05 | Parks Diane L. | Director | A-Award | A | Option to purchase common stock | 26,000 | 21.79 | 566.5K | 26,000 | — | ↗ |
| 2024-06-05 | Malley Thomas | Director | A-Award | A | Option to purchase common stock | 26,000 | 21.79 | 566.5K | 26,000 | — | ↗ |
| 2024-06-05 | Hasnain Faheem | Director | A-Award | A | Option to purchase common stock | 26,000 | 21.79 | 566.5K | 26,000 | — | ↗ |
| 2024-06-05 | Collins Helen Louise | Director | A-Award | A | Option to purchase common stock | 26,000 | 21.79 | 566.5K | 26,000 | — | ↗ |
| 2024-05-20 | Bair Teresa Brophy | Officer | S-Sale | D | Common Stock | 2,615 | 22.15 | 57.9K | 68,979 | — | ↗ |
| 2024-01-30 | DALE STEPHEN | Officer | S-Sale | D | Common Stock | 4,825 | 21.55 | 104.0K | 38,817 | — | ↗ |
| 2024-01-29 | FORD KATHLEEN | Officer | S-Sale | D | Common Stock | 1,496 | 17.80 | 26.6K | 21,602 | — | ↗ |
| 2024-01-29 | DOYLE THOMAS JAMES | Officer | S-Sale | D | Common Stock | 761 | 17.80 | 13.5K | 49,056 | — | ↗ |
| 2024-01-29 | DALE STEPHEN | Officer | S-Sale | D | Common Stock | 2,758 | 17.80 | 49.1K | 43,642 | — | ↗ |
| 2024-01-29 | Bair Teresa Brophy | Officer | S-Sale | D | Common Stock | 2,053 | 17.80 | 36.5K | 68,979 | — | ↗ |
| 2024-01-24 | WILSON TROY EDWARD | Director / Officer | M-Exempt | A | Common Stock | 84,107 | 6.15 | 517.3K | 84,666 | — | ↗ |
| 2024-01-02 | WILSON TROY EDWARD | Director / Officer | A-Award | A | Option to purchase common stock | 560,000 | 15.36 | 8.60M | 560,000 | — | ↗ |
| 2024-01-02 | Powl Brian T. | Officer | A-Award | A | Common Stock | 15,000 | 0.00 | — | 15,000 | — | ↗ |
| 2024-01-02 | FORD KATHLEEN | Officer | A-Award | A | Option to purchase common stock | 185,000 | 15.36 | 2.84M | 185,000 | — | ↗ |
| 2024-01-02 | DOYLE THOMAS JAMES | Officer | A-Award | A | Option to purchase common stock | 42,500 | 15.36 | 652.8K | 42,500 | — | ↗ |
| 2024-01-02 | DALE STEPHEN | Officer | A-Award | A | Option to purchase common stock | 185,000 | 15.36 | 2.84M | 185,000 | — | ↗ |
| 2024-01-02 | Bair Teresa Brophy | Officer | A-Award | A | Common Stock | 46,250 | 0.00 | — | 71,032 | — | ↗ |
| 2023-12-07 | WILSON TROY EDWARD | Director / Officer | G-Gift | D | Common Stock | 1,000 | 0.00 | — | 279,194 | — | ↗ |
| 2023-08-14 | Powl Brian T. | Officer | A-Award | A | Option to purchase common stock | 200,000 | 11.72 | 2.34M | 200,000 | — | ↗ |
| 2023-06-16 | Malley Thomas | Director | P-Purchase | A | Common stock | 50,000 | 11.50 | 575.0K | 139,557 | — | ↗ |
| 2023-06-02 | WILSON TROY EDWARD | Director / Officer | J-Other | D | Common Stock | 300,000 | 0.00 | — | 580,194 | — | ↗ |
| 2023-05-31 | Szela Mary T | Director | A-Award | A | Option to purchase common stock | 26,000 | 13.32 | 346.3K | 26,000 | — | ↗ |
| 2023-05-31 | SCHAFER CAROL | Director | A-Award | A | Option to purchase common stock | 26,000 | 13.32 | 346.3K | 26,000 | — | ↗ |
| 2023-05-31 | Parks Diane L. | Director | A-Award | A | Option to purchase common stock | 26,000 | 13.32 | 346.3K | 26,000 | — | ↗ |
| 2023-05-31 | Malley Thomas | Director | A-Award | A | Option to purchase common stock | 26,000 | 13.32 | 346.3K | 26,000 | — | ↗ |
| 2023-05-31 | Hasnain Faheem | Director | A-Award | A | Option to purchase common stock | 26,000 | 13.32 | 346.3K | 26,000 | — | ↗ |
| 2023-05-31 | Collins Helen Louise | Director | A-Award | A | Option to purchase common stock | 26,000 | 13.32 | 346.3K | 26,000 | — | ↗ |
| 2023-02-16 | WILSON TROY EDWARD | Director / Officer | A-Award | A | Option to purchase common stock | 560,000 | 11.99 | 6.71M | 560,000 | — | ↗ |
| 2023-02-16 | FORD KATHLEEN | Officer | A-Award | A | Option to purchase common stock | 185,000 | 11.99 | 2.22M | 185,000 | — | ↗ |
| 2023-02-16 | DOYLE THOMAS JAMES | Officer | A-Award | A | Common Stock | 10,625 | 0.00 | — | 27,466 | — | ↗ |
| 2023-02-16 | DALE STEPHEN | Officer | A-Award | A | Common Stock | 23,125 | 0.00 | — | 50,800 | — | ↗ |
| 2023-02-16 | Bair Teresa Brophy | Officer | A-Award | A | Common Stock | 23,125 | 0.00 | — | 23,125 | — | ↗ |
| 2023-01-27 | FORD KATHLEEN | Officer | S-Sale | D | Common Stock | 1,821 | 13.89 | 25.3K | 21,214 | — | ↗ |
| 2023-01-27 | FLOWERS KIRSTEN | Officer | S-Sale | D | Common Stock | 1,906 | 13.89 | 26.5K | 20,605 | — | ↗ |
| 2023-01-27 | DOYLE THOMAS JAMES | Officer | S-Sale | D | Common Stock | 866 | 13.89 | 12.0K | 16,841 | — | ↗ |
| 2023-01-27 | DALE STEPHEN | Officer | S-Sale | D | Common Stock | 4,840 | 13.87 | 67.1K | 27,675 | — | ↗ |
| 2022-11-17 | Bair Teresa Brophy | Officer | S-Sale | D | Common Stock | 2,100 | 15.22 | 32.0K | 0 | — | ↗ |
| 2022-10-06 | WILSON TROY EDWARD | Director / Officer | J-Other | A | Common Stock | 1,084,300 | 0.00 | — | 1,125,618 | — | ↗ |
| 2022-08-19 | WILSON TROY EDWARD | Director / Officer | J-Other | D | Common Stock | 11,985 | 0.00 | — | 30,525 | — | ↗ |
| 2022-07-14 | WILSON TROY EDWARD | Director / Officer | J-Other | D | Common Stock | 468,297 | 0.00 | — | 1,151,720 | — | ↗ |
| 2022-06-21 | Szela Mary T | Director | A-Award | A | Option to purchase common stock | 23,000 | 0.00 | — | 23,000 | — | ↗ |
| 2022-06-21 | Stein Steven H | Director | A-Award | A | Option to purchase common stock | 23,000 | 0.00 | — | 23,000 | — | ↗ |
| 2022-06-21 | SCHAFER CAROL | Director | A-Award | A | Option to purchase common stock | 23,000 | 0.00 | — | 23,000 | — | ↗ |
| 2022-06-21 | Parks Diane L. | Director | A-Award | A | Option to purchase common stock | 23,000 | 0.00 | — | 23,000 | — | ↗ |
| 2022-06-21 | Malley Thomas | Director | A-Award | A | Option to purchase common stock | 23,000 | 0.00 | — | 23,000 | — | ↗ |
| 2022-06-21 | Hasnain Faheem | Director | A-Award | A | Option to purchase common stock | 23,000 | 0.00 | — | 23,000 | — | ↗ |
| 2022-06-21 | Collins Helen Louise | Director | A-Award | A | Option to purchase common stock | 23,000 | 0.00 | — | 23,000 | — | ↗ |
| 2022-02-07 | DOYLE THOMAS JAMES | Officer | — | D | Common Stock | 0 | 0.00 | — | 6,610 | — | ↗ |
| 2022-01-26 | WILSON TROY EDWARD | Director / Officer | A-Award | A | Option to purchase common stock | 495,000 | 14.15 | 7.00M | 495,000 | — | ↗ |
| 2022-01-26 | GRASSO MARC | Officer | A-Award | A | Option to purchase common stock | 131,000 | 14.15 | 1.85M | 131,000 | — | ↗ |
| 2022-01-26 | FORD KATHLEEN | Officer | A-Award | A | Option to purchase common stock | 171,000 | 14.15 | 2.42M | 171,000 | — | ↗ |
| 2022-01-26 | FLOWERS KIRSTEN | Officer | A-Award | A | Option to purchase common stock | 171,000 | 14.15 | 2.42M | 171,000 | — | ↗ |
| 2022-01-26 | DALE STEPHEN | Officer | A-Award | A | Option to purchase common stock | 261,000 | 14.15 | 3.69M | 261,000 | — | ↗ |
| 2021-10-18 | Bair Teresa Brophy | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-07-28 | Collins Helen Louise | Director | A-Award | A | Option to purchase common stock | 46,000 | 18.98 | 873.1K | 46,000 | — | ↗ |
| 2021-06-22 | Szela Mary T | Director | A-Award | A | Option to purchase common stock | 23,000 | 21.54 | 495.4K | 23,000 | — | ↗ |
| 2021-06-22 | Stein Steven H | Director | A-Award | A | Option to purchase common stock | 23,000 | 21.54 | 495.4K | 23,000 | — | ↗ |
| 2021-06-22 | SCHAFER CAROL | Director | A-Award | A | Option to purchase common stock | 23,000 | 21.54 | 495.4K | 23,000 | — | ↗ |
| 2021-06-22 | Parks Diane L. | Director | A-Award | A | Option to purchase common stock | 23,000 | 21.54 | 495.4K | 23,000 | — | ↗ |
| 2021-06-22 | Malley Thomas | Director | A-Award | A | Option to purchase common stock | 23,000 | 21.54 | 495.4K | 23,000 | — | ↗ |
| 2021-06-22 | Hasnain Faheem | Director | A-Award | A | Option to purchase common stock | 23,000 | 21.54 | 495.4K | 23,000 | — | ↗ |
| 2021-06-22 | HOFFMAN ROBERT | Director | A-Award | A | Option to purchase common stock | 23,000 | 21.54 | 495.4K | 23,000 | — | ↗ |
| 2021-06-03 | SCHAFER CAROL | Director | A-Award | A | Option to purchase common stock | 46,000 | 21.41 | 984.9K | 46,000 | — | ↗ |
| 2021-03-15 | FORD KATHLEEN | Officer | M-Exempt | D | Option to purchase common stock | 6,250 | 19.43 | 121.4K | 215,625 | — | ↗ |
| 2021-01-26 | WILSON TROY EDWARD | Director / Officer | A-Award | A | Option to purchase common stock | 366,500 | 32.80 | 12.02M | 366,500 | — | ↗ |
| 2021-01-26 | GRASSO MARC | Officer | A-Award | A | Option to purchase common stock | 175,000 | 32.80 | 5.74M | 175,000 | — | ↗ |
| 2021-01-26 | FORD KATHLEEN | Officer | A-Award | A | Option to purchase common stock | 140,000 | 32.80 | 4.59M | 140,000 | — | ↗ |
| 2021-01-26 | FLOWERS KIRSTEN | Officer | A-Award | A | Option to purchase common stock | 125,000 | 32.80 | 4.10M | 125,000 | — | ↗ |
| 2021-01-26 | DALE STEPHEN | Officer | A-Award | A | Option to purchase common stock | 100,000 | 32.80 | 3.28M | 100,000 | — | ↗ |
| 2021-01-26 | BASTA JAMES | Officer | A-Award | A | Option to purchase common stock | 125,000 | 32.80 | 4.10M | 125,000 | — | ↗ |
| 2020-12-23 | WILSON TROY EDWARD | Director / Officer | J-Other | D | Common Stock | 175,000 | 0.00 | — | 1,620,017 | — | ↗ |
| 2020-12-15 | FORD KATHLEEN | Officer | M-Exempt | A | Common Stock | 3,125 | 19.43 | 60.7K | 3,125 | — | ↗ |
| 2020-12-01 | WILSON TROY EDWARD | Director / Officer | M-Exempt | D | Option to purchase common stock | 11,855 | 6.15 | 72.9K | 90,210 | — | ↗ |
| 2020-11-10 | FORD KATHLEEN | Officer | M-Exempt | D | Option to purchase common stock | 6,250 | 19.43 | 121.4K | 231,250 | — | ↗ |
| 2020-10-08 | WILSON TROY EDWARD | Director / Officer | M-Exempt | D | Option to purchase common stock | 50,370 | 6.15 | 309.8K | 102,065 | — | ↗ |
| 2020-10-07 | WILSON TROY EDWARD | Director / Officer | S-Sale | D | Common Stock | 99,900 | 32.00 | 3.20M | 106,736 | — | ↗ |
| 2020-10-06 | WILSON TROY EDWARD | Director / Officer | S-Sale | D | Common Stock | 100 | 32.00 | 3.2K | 206,636 | — | ↗ |
| 2020-09-15 | FORD KATHLEEN | Officer | M-Exempt | D | Option to purchase common stock | 6,250 | 19.43 | 121.4K | 237,500 | — | ↗ |
| 2020-09-14 | WILSON TROY EDWARD | Director / Officer | S-Sale | D | Common Stock | 98,490 | 28.82 | 2.84M | 206,736 | — | ↗ |
| 2020-09-14 | GRASSO MARC | Officer | M-Exempt | D | Option to purchase common stock | 2,102 | 19.40 | 40.8K | 247,898 | — | ↗ |
| 2020-09-14 | FORD KATHLEEN | Officer | M-Exempt | D | Option to purchase common stock | 6,250 | 19.43 | 121.4K | 243,750 | — | ↗ |
| 2020-09-11 | WILSON TROY EDWARD | Director / Officer | S-Sale | D | Common Stock | 17,926 | 28.00 | 501.9K | 28,096 | — | ↗ |
| 2020-09-10 | WILSON TROY EDWARD | Director / Officer | S-Sale | D | Common Stock | 1,025 | 28.00 | 28.7K | 305,711 | — | ↗ |
| 2020-09-08 | WILSON TROY EDWARD | Director / Officer | S-Sale | D | Common Stock | 50,000 | 26.00 | 1.30M | 306,736 | — | ↗ |
| 2020-09-08 | GRASSO MARC | Officer | S-Sale | D | Common Stock | 10,000 | 26.00 | 260.0K | 0 | — | ↗ |
| 2020-08-25 | WILSON TROY EDWARD | Director / Officer | M-Exempt | A | Common Stock | 22,838 | 6.15 | 140.5K | 50,934 | — | ↗ |
| 2020-08-25 | GRASSO MARC | Officer | S-Sale | D | Common Stock | 10,000 | 23.00 | 230.0K | 0 | — | ↗ |
| 2020-08-24 | WILSON TROY EDWARD | Director / Officer | S-Sale | D | Common Stock | 6,568 | 22.04 | 144.8K | 28,096 | — | ↗ |
| 2020-08-24 | Martell Bridget A | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-08-24 | DALE STEPHEN | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-08-19 | WILSON TROY EDWARD | Director / Officer | M-Exempt | D | Option to purchase common stock | 11,913 | 4.80 | 57.2K | 13,728 | — | ↗ |
| 2020-08-18 | WILSON TROY EDWARD | Director / Officer | S-Sale | D | Common Stock | 521 | 22.00 | 11.5K | 28,096 | — | ↗ |
| 2020-08-17 | WILSON TROY EDWARD | Director / Officer | M-Exempt | D | Option to purchase common stock | 12,901 | 4.80 | 61.9K | 26,162 | — | ↗ |
| 2020-08-07 | GRASSO MARC | Officer | M-Exempt | D | Option to purchase common stock | 7,102 | 15.47 | 109.9K | 132,898 | — | ↗ |
| 2020-06-24 | Szela Mary T | Director | A-Award | A | Option to purchase common stock | 23,000 | 17.97 | 413.3K | 23,000 | — | ↗ |
| 2020-06-24 | Stein Steven H | Director | A-Award | A | Option to purchase common stock | 23,000 | 17.97 | 413.3K | 23,000 | — | ↗ |
| 2020-06-24 | Parks Diane L. | Director | A-Award | A | Option to purchase common stock | 23,000 | 17.97 | 413.3K | 23,000 | — | ↗ |
| 2020-06-24 | Malley Thomas | Director | A-Award | A | Option to purchase common stock | 23,000 | 17.97 | 413.3K | 23,000 | — | ↗ |
| 2020-06-24 | Hasnain Faheem | Director | A-Award | A | Option to purchase common stock | 23,000 | 17.97 | 413.3K | 23,000 | — | ↗ |
| 2020-06-24 | HOFFMAN ROBERT | Director | A-Award | A | Option to purchase common stock | 23,000 | 17.97 | 413.3K | 23,000 | — | ↗ |
| 2020-03-12 | BASTA JAMES | Officer | A-Award | A | Option to purchase common stock | 25,000 | 8.41 | 210.3K | 25,000 | — | ↗ |
| 2020-02-11 | WILSON TROY EDWARD | Director / Officer | M-Exempt | D | Option to purchase common stock | 1,185 | 6.15 | 7.3K | 234,815 | — | ↗ |
| 2020-02-10 | Martell Bridget A | Officer | A-Award | A | Option to purchase common stock | 50,000 | 12.22 | 611.0K | 50,000 | — | ↗ |
| 2020-01-30 | WILSON TROY EDWARD | Director / Officer | A-Award | A | Option to purchase common stock | 393,950 | 11.86 | 4.67M | 393,950 | — | ↗ |
| 2020-01-30 | GRASSO MARC | Officer | A-Award | A | Option to purchase common stock | 111,723 | 11.86 | 1.33M | 111,723 | — | ↗ |
| 2020-01-30 | FORD KATHLEEN | Officer | A-Award | A | Option to purchase common stock | 45,393 | 11.86 | 538.4K | 45,393 | — | ↗ |
| 2020-01-06 | FLOWERS KIRSTEN | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-11-04 | BASTA JAMES | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-10-14 | Parks Diane L. | Director | A-Award | A | Option to purchase common stock | 30,000 | 13.78 | 413.4K | 30,000 | — | ↗ |
| 2019-08-09 | FORD KATHLEEN | Officer | A-Award | A | Option to purchase common stock | 250,000 | 19.43 | 4.86M | 250,000 | — | ↗ |
| 2019-07-10 | GUALBERTO ANTONIO | Officer | M-Exempt | A | Common Stock | 18,000 | 6.15 | 110.7K | 357,973 | — | ↗ |
| 2019-06-25 | Szela Mary T | Director | A-Award | A | Option to purchase common stock | 13,000 | 19.55 | 254.2K | 13,000 | — | ↗ |
| 2019-06-25 | Stein Steven H | Director | A-Award | A | Option to purchase common stock | 13,000 | 19.55 | 254.2K | 13,000 | — | ↗ |
| 2019-06-25 | Malley Thomas | Director | A-Award | A | Option to purchase common stock | 13,000 | 19.55 | 254.2K | 13,000 | — | ↗ |
| 2019-06-25 | Hasnain Faheem | Director | A-Award | A | Option to purchase common stock | 13,000 | 19.55 | 254.2K | 13,000 | — | ↗ |
| 2019-06-25 | HOFFMAN ROBERT | Director | A-Award | A | Option to purchase common stock | 13,000 | 19.55 | 254.2K | 13,000 | — | ↗ |
| 2019-01-22 | WILSON TROY EDWARD | Director / Officer | A-Award | A | Option to purchase common stock | 220,000 | 15.47 | 3.40M | 220,000 | — | ↗ |
| 2019-01-22 | REN PINGDA | Officer | A-Award | A | Option to purchase common stock | 75,000 | 15.47 | 1.16M | 75,000 | — | ↗ |
| 2019-01-22 | North Annette | Officer | A-Award | A | Option to purchase common stock | 100,000 | 15.47 | 1.55M | 100,000 | — | ↗ |
| 2019-01-22 | GUALBERTO ANTONIO | Officer | A-Award | A | Option to purchase common stock | 140,000 | 15.47 | 2.17M | 140,000 | — | ↗ |
| 2019-01-22 | GRASSO MARC | Officer | A-Award | A | Option to purchase common stock | 140,000 | 15.47 | 2.17M | 140,000 | — | ↗ |
| 2019-01-22 | FARNAM JOHN | Officer | A-Award | A | Option to purchase common stock | 125,000 | 15.47 | 1.93M | 125,000 | — | ↗ |
| 2018-12-31 | WILSON TROY EDWARD | Director / Officer | — | I | Common Stock | 0 | 0.00 | — | 406,736 | — | ↗ |
| 2018-12-21 | EcoR1 Capital Fund Qualified, L.P. | 10% Owner | P-Purchase | A | Common Stock | 83,540 | 13.16 | 1.10M | 4,408,097 | — | ↗ |
| 2018-12-19 | EcoR1 Capital Fund Qualified, L.P. | 10% Owner | P-Purchase | A | Common Stock | 51,879 | 13.84 | 718.0K | 4,324,557 | — | ↗ |
| 2018-12-18 | EcoR1 Capital Fund Qualified, L.P. | 10% Owner | P-Purchase | A | Common Stock | 78,469 | 13.82 | 1.08M | 4,272,678 | — | ↗ |
| 2018-12-17 | EcoR1 Capital Fund Qualified, L.P. | 10% Owner | S-Sale | D | Common Stock | 26,520 | 13.20 | 350.1K | 4,194,209 | — | ↗ |
| 2018-12-13 | EcoR1 Capital Fund Qualified, L.P. | 10% Owner | P-Purchase | A | Common Stock | 25,217 | 13.89 | 350.3K | 4,220,729 | — | ↗ |
| 2018-12-11 | EcoR1 Capital Fund Qualified, L.P. | 10% Owner | P-Purchase | A | Common Stock | 15,321 | 13.91 | 213.1K | 4,195,512 | — | ↗ |
| 2018-12-06 | EcoR1 Capital Fund Qualified, L.P. | 10% Owner | P-Purchase | A | Common Stock | 17,079 | 13.49 | 230.4K | 4,180,919 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-11.7K
Shares Outstanding
88.76M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Troy E. Wilson, Ph.D., J.D. President and Chief Executive Officer | 700.0K | — | — | 3.30M | 630.0K | 107.8K | 4.74M | 69.64% | ↗ |
| 2 | 2025 | Brian Powl Chief Commercial Officer | 506.3K | — | 1.37M | 488.0K | 291.2K | 17.5K | 2.67M | 69.47% | ↗ |
| 3 | 2025 | Kathleen Ford Chief Operating Officer | 539.9K | — | — | 976.0K | 310.5K | 76.1K | 1.90M | 51.30% | ↗ |
| 4 | 2024 | Troy E. Wilson, Ph.D., J.D. President and Chief Executive Officer | 671.7K | — | — | 4.94M | 538.1K | 89.7K | 6.24M | 79.18% | ↗ |
| 5 | 2024 | Stephen Dale, M.D. Former Chief Medical Officer | 575.1K | — | — | 1.63M | 283.4K | 17.3K | 2.51M | 65.09% | ↗ |
| 6 | 2024 | Kathleen Ford Chief Operating Officer | 519.2K | — | — | 1.63M | 259.8K | 94.3K | 2.51M | 65.15% | ↗ |
| 7 | 2024 | Teresa Bair, J.D. Chief Legal Officer and Secretary | 468.5K | — | 710.4K | 816.5K | 246.2K | 30.3K | 2.27M | 67.21% | ↗ |
| 8 | 2023 | Troy E. Wilson, Ph.D., J.D. President and Chief Executive Officer | 645.9K | — | — | 4.03M | 479.6K | 91.2K | 5.25M | 76.83% | ↗ |
| 9 | 2023 | Stephen Dale, M.D. Former Chief Medical Officer | 538.3K | — | 277.3K | 1.33M | 291.0K | 26.0K | 2.47M | 65.31% | ↗ |
| 10 | 2023 | Stephen Dale, M.D. Chief Medical Officer | 538.3K | — | 277.3K | 1.33M | 291.0K | 26.0K | 2.47M | 65.31% | ↗ |
| 11 | 2023 | Kathleen Ford Chief Operating Officer | 499.2K | — | — | 1.33M | 252.1K | 73.7K | 2.16M | 61.77% | ↗ |
| 12 | 2023 | Teresa Bair, J.D. Chief Legal Officer and Secretary | 442.0K | — | 277.3K | 999.7K | 223.2K | 40.2K | 1.98M | 64.42% | ↗ |
| 13 | 2022 | Troy E. Wilson, Ph.D., J.D. President and Chief Executive Officer | 621.0K | 119.5K | — | 4.24M | 263.0K | 58.4K | 5.30M | 79.98% | ↗ |
| 14 | 2022 | Stephen Dale, M.D. Chief Medical Officer | 463.6K | 47.5K | 522.1K | 2.24M | 161.1K | 12.2K | 3.44M | 80.12% | ↗ |
| 15 | 2022 | Stephen Dale, M.D. Former Chief Medical Officer | 463.6K | 47.5K | 522.1K | 2.24M | 161.1K | 12.2K | 3.44M | 80.12% | ↗ |
| 16 | 2022 | Kathleen Ford Chief Operating Officer | 480.0K | 50.4K | 309.9K | 1.47M | 158.9K | 65.0K | 2.53M | 70.18% | ↗ |
| 17 | 2022 | Kirsten Flowers Former Chief Commercial and Corporate Strategy Officer | 466.3K | 49.9K | 309.9K | 1.47M | 157.2K | 51.7K | 2.50M | 71.00% | ↗ |
| 18 | 2022 | Marc Grasso, M.D. Former Chief Financial Officer and Chief Business Officer | 45.6K | — | 309.9K | 1.27M | — | 64.9K | 1.69M | 93.48% | ↗ |
| 19 | 2021 | Troy E. Wilson, Ph.D., J.D. President and Chief Executive Officer | 600.0K | 94.9K | — | 7.76M | 202.1K | 87.6K | 8.74M | 88.74% | ↗ |
| 20 | 2021 | Marc Grasso, M.D. Former Chief Financial Officer and Chief Business Officer | 446.3K | 38.5K | — | 3.70M | 126.6K | 40.3K | 4.36M | 85.04% | ↗ |
| 21 | 2021 | Kathleen Ford Chief Operating Officer | 463.3K | 40.0K | — | 2.96M | 131.4K | 54.7K | 3.65M | 81.13% | ↗ |
| 22 | 2021 | Kirsten Flowers Chief Commercial Officer | 442.0K | 38.1K | — | 2.65M | 125.4K | 37.4K | 3.29M | 80.45% | ↗ |
| 23 | 2021 | Kirsten Flowers Former Chief Commercial and Corporate Strategy Officer | 442.0K | 38.1K | — | 2.65M | 125.4K | 37.4K | 3.29M | 80.45% | ↗ |
| 24 | 2021 | Stephen Dale, M.D. Chief Medical Officer | 489.0K | 119.6K | — | 2.12M | 183.9K | 19.1K | 2.93M | 72.29% | ↗ |
| 25 | 2020 | Troy E. Wilson, Ph.D., J.D. President and Chief Executive Officer | 573.0K | — | — | 3.08M | 441.2K | 99.0K | 4.19M | 73.44% | ↗ |
| 26 | 2020 | Stephen Dale, M.D. Chief Medical Officer | 158.6K | 150.0K | — | 2.89M | 81.8K | 8.6K | 3.29M | 87.86% | ↗ |
| 27 | 2020 | Kirsten Flowers Chief Commercial Officer | 420.4K | — | — | 2.29M | 218.0K | 17.0K | 2.95M | 77.77% | ↗ |
| 28 | 2020 | Kirsten Flowers Former Chief Commercial and Corporate Strategy Officer | 420.4K | — | — | 2.29M | 218.0K | 17.0K | 2.95M | 77.77% | ↗ |
| 29 | 2020 | Bridget Martell, M.A., M.D. Former Acting Chief Medical Officer | 397.7K | — | — | 1.36M | 221.0K | 449.4K | 2.43M | 56.07% | ↗ |
| 30 | 2020 | Marc Grasso, M.D. Former Chief Financial Officer and Chief Business Officer | 415.0K | — | — | 873.2K | 257.3K | 43.6K | 1.59M | 54.95% | ↗ |
| 31 | 2020 | Marc Grasso, M.D. Chief Financial Officer and Chief Business Officer | 415.0K | — | — | 873.2K | 257.3K | 43.6K | 1.59M | 54.95% | ↗ |
| 32 | 2020 | Kathleen Ford Chief Operating Officer | 425.0K | — | — | 354.8K | 221.0K | 37.4K | 1.04M | 34.17% | ↗ |
| 33 | 2019 | Kathleen Ford Chief Operating Officer | 157.7K | — | — | 3.23M | 61.9K | 31.3K | 3.49M | 92.80% | ↗ |
| 34 | 2019 | Troy E. Wilson, Ph.D., J.D. President and Chief Executive Officer | 542.0K | — | — | 2.33M | 290.3K | 76.0K | 3.24M | 71.93% | ↗ |
| 35 | 2019 | John Farnam Former Chief Operating Officer | 236.2K | — | — | 1.40M | — | 527.2K | 2.16M | 64.72% | ↗ |
| 36 | 2019 | Marc Grasso, M.D. Former Chief Financial Officer and Chief Business Officer | 387.8K | — | — | 1.48M | 152.9K | 90.2K | 2.11M | 70.13% | ↗ |
| 37 | 2019 | Marc Grasso, M.D. Chief Financial Officer and Chief Business Officer | 387.8K | — | — | 1.48M | 152.9K | 90.2K | 2.11M | 70.13% | ↗ |
| 38 | 2019 | Antonio Gualberto, M.D., Ph.D. Former Head of Development and Chief Medical Officer | 431.0K | — | — | 1.48M | 125.9K | 11.9K | 2.05M | 72.26% | ↗ |
| 39 | 2019 | James Basta, J.D. Chief Legal Officer and Secretary | 63.7K | 100.0K | — | 1.76M | — | 5.2K | 1.93M | 91.26% | ↗ |
| 40 | 2018 | Troy E. Wilson, Ph.D., J.D. President and Chief Executive Officer | 526.4K | — | — | 3.79M | 368.5K | 56.6K | 4.75M | 79.95% | ↗ |
| 41 | 2018 | Marc Grasso, M.D. Chief Financial Officer, Chief Business Officer and Secretary | 136.9K | 100.0K | — | 3.29M | 69.4K | 40.0K | 3.63M | 90.47% | ↗ |
| 42 | 2018 | Marc Grasso, M.D. Chief Financial Officer and Chief Business Officer | 136.9K | 100.0K | — | 3.29M | 69.4K | 40.0K | 3.63M | 90.47% | ↗ |
| 43 | 2018 | Antonio Gualberto, M.D., Ph.D. Former Head of Development and Chief Medical Officer | 415.0K | — | — | 1.38M | 215.8K | 11.4K | 2.02M | 68.24% | ↗ |
| 44 | 2018 | Antonio Gualberto, M.D., Ph.D. Head of Development and Chief Medical Officer | 415.0K | — | — | 1.38M | 215.8K | 11.4K | 2.02M | 68.24% | ↗ |
| 45 | 2018 | John Farnam Former Chief Operating Officer | 177.5K | — | — | 1.44M | 92.6K | 6.6K | 1.72M | 83.89% | ↗ |
| 46 | 2017 | Troy E. Wilson, Ph.D., J.D. President and Chief Executive Officer | 471.9K | — | — | 979.1K | 259.5K | 10.6K | 1.72M | 56.89% | ↗ |
| 47 | 2017 | Antonio Gualberto, M.D., Ph.D. Former Head of Development and Chief Medical Officer | 393.1K | — | — | 701.1K | 153.5K | 10.3K | 1.26M | 55.73% | ↗ |
| 48 | 2017 | Antonio Gualberto, M.D., Ph.D. Head of Development and Chief Medical Officer | 393.1K | — | — | 701.1K | 153.5K | 10.3K | 1.26M | 55.73% | ↗ |
| 49 | 2017 | Heidi Henson Chief Financial Officer and Secretary | 334.1K | — | — | 414.9K | 136.5K | 10.9K | 896.3K | 46.28% | ↗ |
| 50 | 2016 | Troy E. Wilson, Ph.D., J.D. President and Chief Executive Officer | 429.0K | — | — | 392.0K | 214.5K | 10.5K | 1.05M | 37.48% | ↗ |
| 51 | 2016 | Antonio Gualberto, M.D., Ph.D. Chief Medical Officer | 380.1K | — | — | 235.2K | 136.3K | 10.7K | 762.3K | 30.85% | ↗ |
| 52 | 2016 | Antonio Gualberto, M.D., Ph.D. Head of Development and Chief Medical Officer | 380.1K | — | — | 235.2K | 136.3K | 10.7K | 762.3K | 30.85% | ↗ |
| 53 | 2016 | Annette North Senior Vice President, General Counsel | 331.9K | — | — | 250.9K | 116.2K | 11.3K | 710.2K | 35.33% | ↗ |
| 54 | 2016 | Heidi Henson Chief Financial Officer and Secretary | 313.9K | — | — | 250.9K | 108.4K | 11.2K | 684.4K | 36.66% | ↗ |
| 55 | 2015 | Annette North Senior Vice President, General Counsel | 292.1K | — | — | 327.2K | 101.5K | 3.3K | 724.1K | 45.19% | ↗ |
| 56 | 2015 | Troy E. Wilson, Ph.D., J.D. President and Chief Executive Officer | 385.0K | — | — | — | 195.0K | 2.4K | 582.4K | 0.00% | ↗ |
| 57 | 2015 | Antonio Gualberto, M.D., Ph.D. Chief Medical Officer | 359.2K | — | — | — | 126.0K | 3.2K | 488.3K | 0.00% | ↗ |
| 58 | 2014 | Troy E. Wilson, Ph.D., J.D. President and Chief Executive Officer | 82.5K | — | 3.5K | — | — | 612.00 | 86.6K | 4.04% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Troy Edward Wilson | Chairman, Chief Executive Officer & President | 1M | — |
| Kathleen Ford | Chief Operating Officer | 926.5K | female |
| Mollie Leoni | Chief Medical Officer | 855.3K | — |
| Brian T. Powl | Chief Commercial Officer | 815.0K | male |
| Teresa Brophy Bair | Chief Legal Officer & Corporate Secretary | 745.0K | female |
| Greg Mann | Senior Vice President of Investor Relations & Corporate Affairs | — | male |
| Roger Bakale | Senior Vice President of Manufacturing & Supply Chain | — | — |
| Samir Vattompadam | Senior Vice President of Global Program Leadership | — | male |
| Thomas Doyle | Senior Vice President of Finance & Accounting | — | male |
| Francis J. Burrows | Chief Scientific Officer | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2022-12-12 | 2023-01-20 | Christopher L. Jacobs | NY27 | — | Purchase | $1,001 - $15,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for KURA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
